Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.

Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, Colin de Verdière N, Slama L, Martin K, Lortholary O, Carrat F; ANRS HB03 VIHVAC-B Trial.

JAMA. 2011 Apr 13;305(14):1432-40. doi: 10.1001/jama.2011.351.

PMID:
21486976
2.

Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?

Ni JD, Xiong YZ, Wang XJ, Xiu LC.

Int J STD AIDS. 2013 Feb;24(2):117-22. doi: 10.1177/0956462412472309. Epub 2013 May 6. Review.

PMID:
23467291
3.

Hepatitis B vaccine by intradermal route in non responder patients: an update.

Filippelli M, Lionetti E, Gennaro A, Lanzafame A, Arrigo T, Salpietro C, La Rosa M, Leonardi S.

World J Gastroenterol. 2014 Aug 14;20(30):10383-94. doi: 10.3748/wjg.v20.i30.10383. Review.

4.

Vaccines for preventing hepatitis B in health-care workers.

Chen W, Gluud C.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD000100. Review.

PMID:
16235273
5.
6.

Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine.

Parish DC, Muecke HW, Joiner TA, Pope WT, Hadler SC.

South Med J. 1991 Apr;84(4):426-30. Review.

PMID:
1826567
7.

Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection.

Okwen MP, Reid S, Njei B, Mbuagbaw L.

Cochrane Database Syst Rev. 2014 Oct 9;(10):CD009886. doi: 10.1002/14651858.CD009886.pub2. Review.

8.

Hepatitis B and A vaccination in HIV-infected adults: A review.

Mena G, García-Basteiro AL, Bayas JM.

Hum Vaccin Immunother. 2015;11(11):2582-98. doi: 10.1080/21645515.2015.1055424. Epub 2015 Jul 24. Review.

9.

Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1.

Whitaker JA, Rouphael NG, Edupuganti S, Lai L, Mulligan MJ.

Lancet Infect Dis. 2012 Dec;12(12):966-76. doi: 10.1016/S1473-3099(12)70243-8. Review.

10.

Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations.

Kim HN, Harrington RD, Crane HM, Dhanireddy S, Dellit TH, Spach DH.

Int J STD AIDS. 2009 Sep;20(9):595-600. doi: 10.1258/ijsa.2009.009126. Review.

PMID:
19710329
11.

Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine.

Walayat S, Ahmed Z, Martin D, Puli S, Cashman M, Dhillon S.

World J Hepatol. 2015 Oct 28;7(24):2503-9. doi: 10.4254/wjh.v7.i24.2503. Review.

12.

Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study.

Rezaee R, Aghcheli B, Poortahmasebi V, Qorbani M, Alavian SM, Jazayeri SM.

Hepat Mon. 2015 Apr 25;15(5):e23618. doi: 10.5812/hepatmon.15(04)2015.23618. eCollection 2015 May. Review.

13.

[Hepatitis B vaccine tolerance: spontaneous reporting and pharmacoepidemiologic studies].

Autret-Leca E, Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salinas F.

Presse Med. 2007 Apr;36(4 Pt 1):563-4. Epub 2007 Feb 27. Review. French. No abstract available.

PMID:
17329069

Supplemental Content

Support Center